JPWO2020067453A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020067453A5 JPWO2020067453A5 JP2020549451A JP2020549451A JPWO2020067453A5 JP WO2020067453 A5 JPWO2020067453 A5 JP WO2020067453A5 JP 2020549451 A JP2020549451 A JP 2020549451A JP 2020549451 A JP2020549451 A JP 2020549451A JP WO2020067453 A5 JPWO2020067453 A5 JP WO2020067453A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- preparation according
- lyophilized preparation
- peptide
- cyclodextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 101800000324 Immunoglobulin A1 protease translocator Proteins 0.000 claims 8
- 229920000858 Cyclodextrin Polymers 0.000 claims 6
- 239000002671 adjuvant Substances 0.000 claims 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 5
- 229960004452 methionine Drugs 0.000 claims 5
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 5
- 229930182817 methionine Natural products 0.000 claims 4
- 150000007524 organic acids Chemical class 0.000 claims 4
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims 4
- 239000004475 Arginine Substances 0.000 claims 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 3
- 239000003002 pH adjusting agent Substances 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims 2
- 239000012931 lyophilized formulation Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 1
- 229930195722 L-methionine Natural products 0.000 claims 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims 1
- 239000008213 purified water Substances 0.000 claims 1
- 239000001384 succinic acid Substances 0.000 claims 1
- 235000002906 tartaric acid Nutrition 0.000 claims 1
- 239000011975 tartaric acid Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018185532 | 2018-09-28 | ||
| JP2018185532 | 2018-09-28 | ||
| PCT/JP2019/038223 WO2020067453A1 (ja) | 2018-09-28 | 2019-09-27 | 注射用組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020067453A1 JPWO2020067453A1 (ja) | 2021-09-09 |
| JPWO2020067453A5 true JPWO2020067453A5 (https=) | 2022-04-08 |
| JP7162675B2 JP7162675B2 (ja) | 2022-10-28 |
Family
ID=69951879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020549451A Active JP7162675B2 (ja) | 2018-09-28 | 2019-09-27 | 注射用組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210338587A1 (https=) |
| EP (1) | EP3858377A4 (https=) |
| JP (1) | JP7162675B2 (https=) |
| KR (1) | KR20210068060A (https=) |
| CN (1) | CN113382746A (https=) |
| AU (1) | AU2019349329A1 (https=) |
| CA (1) | CA3113212A1 (https=) |
| MX (1) | MX2021003660A (https=) |
| NZ (1) | NZ774063A (https=) |
| WO (1) | WO2020067453A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024149926A (ja) * | 2021-08-06 | 2024-10-23 | ブライトパス・バイオ株式会社 | がんペプチドワクチンカクテル製剤、及びその製造方法 |
| EP4709424A1 (en) * | 2023-05-08 | 2026-03-18 | Integro Theranostics, LLC | Lyophilized products, pharmaceutical compositions, and kits comprising dye-peptide conjugates and derivatives |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4932199A (en) | 1998-07-31 | 2000-02-21 | Haruo Sugiyama | Cancer antigens based on tumor suppressor gene wt1 product |
| AR021849A1 (es) | 1998-09-30 | 2002-08-07 | Corixa Corp | Composiciones y metodos para la inmunoterapia especifica de wt1 |
| US20030072767A1 (en) | 1998-09-30 | 2003-04-17 | Alexander Gaiger | Compositions and methods for WT1 specific immunotherapy |
| US20030235557A1 (en) | 1998-09-30 | 2003-12-25 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| WO2002047474A1 (en) | 2000-12-13 | 2002-06-20 | Sumitomo Pharmaceuticals Company, Limited | Transgenic animal expressing hla-a24 and utilization thereof |
| EP1371664B1 (en) | 2001-03-22 | 2008-01-09 | International Institute of Cancer Immunology, Inc. | Wti modified peptide |
| US7553494B2 (en) | 2001-08-24 | 2009-06-30 | Corixa Corporation | WT1 fusion proteins |
| WO2003106682A1 (ja) | 2002-06-12 | 2003-12-24 | 中外製薬株式会社 | Hla−a24拘束性癌抗原ペプチド |
| ES2331305T3 (es) | 2002-09-20 | 2009-12-29 | International Institute Of Cancer Immunology, Inc. | Peptidos de wt1 de tipo sustituido. |
| US7353321B2 (en) | 2003-01-13 | 2008-04-01 | Sierra Logic | Integrated-circuit implementation of a storage-shelf router and a path controller card for combined use in high-availability mass-storage-device shelves that may be incorporated within disk arrays |
| KR101213015B1 (ko) | 2003-11-05 | 2012-12-26 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | Wt1 로부터 유도된 hla-dr 결합성 항원 펩티드 |
| CA2548135C (en) | 2003-12-01 | 2014-04-22 | Sloan-Kettering Institute For Cancer Research | Synthetic hla binding peptide analogues and uses thereof |
| EP1844789B8 (en) | 2005-01-19 | 2014-10-08 | Sumitomo Dainippon Pharma Co., Ltd. | Emulsified composition for dilution and cancer vaccine composition |
| EP1951281B1 (en) | 2005-10-17 | 2015-04-15 | Sloan Kettering Institute For Cancer Research | Wt1 hla class ii-binding peptides and compositions and methods comprising same |
| CA2631292C (en) | 2005-11-30 | 2014-05-06 | International Institute Of Cancer Immunology, Inc. | Derivatised wt1 cancer antigen peptides and their use |
| WO2007120673A2 (en) | 2006-04-10 | 2007-10-25 | Sloan Kettering Institute For Cancer Research | Immunogenic wt-1 peptides and methods of use thereof |
| WO2009046738A1 (en) * | 2007-10-09 | 2009-04-16 | Curevac Gmbh | Composition for treating lung cancer, particularly of non-small lung cancers (nsclc) |
| EP2337795A2 (en) | 2008-10-01 | 2011-06-29 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| AR076349A1 (es) | 2009-04-23 | 2011-06-01 | Int Inst Cancer Immunology Inc | Peptido auxiliar del antigeno del cancer |
| SG11201507883SA (en) * | 2013-03-29 | 2015-10-29 | Sumitomo Dainippon Pharma Co Ltd | Wt1-antigen peptide conjugate vaccine |
| ES2916834T3 (es) * | 2014-09-27 | 2022-07-06 | Sumitomo Pharma Co Ltd | Composición farmacéutica para inyección |
| CN107921106B (zh) | 2015-05-20 | 2023-09-08 | 住友制药株式会社 | Wt1抗原肽和免疫调节剂的组合用途 |
| US12383608B2 (en) | 2016-11-30 | 2025-08-12 | Sumitomo Pharma Co., Ltd. | WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides |
-
2019
- 2019-09-27 JP JP2020549451A patent/JP7162675B2/ja active Active
- 2019-09-27 WO PCT/JP2019/038223 patent/WO2020067453A1/ja not_active Ceased
- 2019-09-27 CA CA3113212A patent/CA3113212A1/en active Pending
- 2019-09-27 NZ NZ774063A patent/NZ774063A/en unknown
- 2019-09-27 KR KR1020217011972A patent/KR20210068060A/ko active Pending
- 2019-09-27 AU AU2019349329A patent/AU2019349329A1/en not_active Abandoned
- 2019-09-27 MX MX2021003660A patent/MX2021003660A/es unknown
- 2019-09-27 US US17/279,807 patent/US20210338587A1/en active Pending
- 2019-09-27 CN CN201980077600.9A patent/CN113382746A/zh active Pending
- 2019-09-27 EP EP19864323.1A patent/EP3858377A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016065060A5 (https=) | ||
| JP2020138981A5 (https=) | ||
| EP2635302B1 (fr) | Procede pour ameliorer la production de virus et semences vaccinales influenza | |
| JP2019504086A5 (https=) | ||
| JP2019131596A5 (https=) | ||
| JP2020518599A5 (https=) | ||
| JP2023113751A5 (https=) | ||
| JPWO2020067453A5 (https=) | ||
| JP2016505044A5 (https=) | ||
| JP2018528242A5 (https=) | ||
| JP2013531679A5 (https=) | ||
| JP2016130266A5 (https=) | ||
| JP2013513612A5 (https=) | ||
| JP2020015742A5 (https=) | ||
| CN108026515A (zh) | 用于预防和/或治疗感染性疾病以及用于治疗肿瘤疾病的减毒流感病毒载体 | |
| US20240261398A1 (en) | Adjuvant and vaccine containing adjuvant | |
| JP2012516879A5 (https=) | ||
| JP2022552520A5 (https=) | ||
| EP2593135B1 (fr) | Souches virales modifiées et procédé pour améliorer la production de semences vaccinales de virus influenza | |
| JP2019516730A5 (https=) | ||
| JP2021502337A5 (https=) | ||
| JP2011524372A (ja) | インフルエンザワクチン接種のための新規ペプチドアジュバント | |
| US12606804B2 (en) | Influenza virus backbone | |
| BE1024228A1 (fr) | Nouvelles formulations d'adjuvants | |
| JP2014524450A5 (https=) |